Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/2002
10/08/2002US6462066 Method and composition for treatment of ischemic neuronal reperfusion injury
10/08/2002US6462056 Oxazolidines as 5-HT2A-antagonists
10/08/2002US6462051 Composition for reducing mental fatigue, composition for maintaining and enhancing concentration, and composition for maintaining and enhancing mental vigor
10/08/2002US6462048 3-(2-(4-methylpiperazin-1-yl)-benzylidene)-1,3-dihydro-indol-2-one for example; useful as psychotherapeutic agents
10/08/2002US6462035 Binding to neuronal nicotinic acetylcholine specific receptor; modulating cholinergic function; reducing nicotine addiction; inflammatory and irritable bowel syndrome, spastic dystonia, chronic and acute pain, eating disorders
10/08/2002US6462022 Lisinopril compositions having large-particle DCPD
10/08/2002US6462017 Method of reducing side effects of chemotherapy in cancer patients
10/08/2002US6461848 Degrades heparin sulfate preventing deposits of beta-amyloid senile plaques
10/08/2002US6461822 Therapeutic targets for agents that suppress the release of inflammatory mediators such as interleukin il-1 and il-1 beta
10/08/2002US6461642 Crystallization using supercritical or subcritical fluids
10/08/2002US6461636 Matrix mass containing (meth)acrylate copolymer having ammonio groups or mixture of (meth)acrylate copolymer having amino groups with one having carboxyl groups, propylene glycol and pergolide surrounded by larger plaster for fixing to skin
10/08/2002US6461602 Water-soluble, nontoxic prodrugs having a hydrolyzable carbamate group coupling the drug or active ingredient to a modified polymer; insoluble drug released in vivo; drug delivery
10/08/2002CA2231046C Human protein kinases hyak3
10/08/2002CA2196769C Benzimidazole derivatives having dopaminergic activity
10/08/2002CA2182486C Cyclic neurokinin a antagonists
10/08/2002CA2108967C Arylmorpholine, preparation and use
10/08/2002CA2066083C Benzodiazepine analogs as cholecystokinin antagonists
10/05/2002CA2380381A1 Combination treatment of multiple sclerosis (ms) other demyelinating conditions and peripheral neuropathy, especially painful neuropathies and diabetic neuropathy
10/03/2002WO2002077237A2 Transporters and ion channels
10/03/2002WO2002077217A2 Human dual specificity protein phosphatase 7-like protein
10/03/2002WO2002077211A2 A virus (cryptovirus) within the rubulavirus genus and uses therefor
10/03/2002WO2002077199A2 Methods and products related to fgf dimerization
10/03/2002WO2002077028A1 Polypeptides and nucleic acids for bolekine
10/03/2002WO2002077021A2 Streptococcus pneumoniae proteins and nucleic acids
10/03/2002WO2002077017A2 Medical uses of intercellular communication facilitating compounds
10/03/2002WO2002076995A2 2-amino-propanol derivatives
10/03/2002WO2002076990A1 Thiazolopyrimidine derivatives and use thereof as antagonists of the cx3 cr1 receptor
10/03/2002WO2002076987A1 (oxo-pyrazolo[1,5a]pyrimidin-2-yl)alkyl-carboxamides
10/03/2002WO2002076986A1 Pyrazolopyrimidines as therapeutic agents
10/03/2002WO2002076984A1 Compounds useful as kinase inhibitors for the treatment of hyperproliferative diseases
10/03/2002WO2002076983A1 Imidazo-pyrimidine derivatives as ligands for gaba receptors
10/03/2002WO2002076979A1 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin ii receptor antagonists
10/03/2002WO2002076977A2 Rho-kinase inhibitors
10/03/2002WO2002076976A2 Rho-kinase inhibitors
10/03/2002WO2002076964A1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same
10/03/2002WO2002076963A1 Bicyclic guanidine derivatives and therapeutic uses thereof
10/03/2002WO2002076957A1 Activator for peroxisome proliferator-activated receptor
10/03/2002WO2002076953A1 New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
10/03/2002WO2002076951A1 2-mercapto-4,5-diarylimidazole derivatives and the use thereof as cyclooxygenase inhibitors
10/03/2002WO2002076950A2 Imidiazole derivatives and their use as agonists selective at alpha 2b or 2b/2c adrenergic receptors
10/03/2002WO2002076949A1 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
10/03/2002WO2002076948A1 Novel piperidine derivatives as modulators of chemokine receptors
10/03/2002WO2002076947A1 Mch antagonists and their use in the treatment of obesity
10/03/2002WO2002076946A2 Fused pyridine derivatives for use as vanilloid receptor antagonists for treating pain.
10/03/2002WO2002076945A1 Aminopyrrolidine sulfonamides as serine protease inhibitors
10/03/2002WO2002076939A2 Cysteine protease inhibitors
10/03/2002WO2002076933A1 Formailide derivatives as beta2-adrenoreceptor agonists
10/03/2002WO2002076929A1 Aryl and biaryl compounds having mch modulatory activity
10/03/2002WO2002076926A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists
10/03/2002WO2002076925A2 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
10/03/2002WO2002076505A1 Remedies for post-traumatic stress disorder
10/03/2002WO2002076503A1 Treatment of central nervous system diseases by antibodies against glatiramer acetate
10/03/2002WO2002076497A2 Method and composition
10/03/2002WO2002076493A1 Novel drugs for preventing/treating immunopathic diseases
10/03/2002WO2002076492A1 Novel agents for ameliorating motor disorder
10/03/2002WO2002076480A1 Cannabis sativa extract for the treatment of migraine
10/03/2002WO2002076476A2 Prodrugs of anticancer agents employing substituted aromatic acids
10/03/2002WO2002076461A1 Combination of reboxetine and citalopram
10/03/2002WO2002076457A1 Novel amides, preparation and therapeutic use as modulators of ccr-receptor activity
10/03/2002WO2002076455A1 Autonomic controlling agents and health drinks and foods
10/03/2002WO2002076452A1 Use of melationin in the manufacture of a medicament for treating attention deficit hyperactive disorder
10/03/2002WO2002076450A1 Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
10/03/2002WO2002076445A1 Agents against stress-induced diseases drugs
10/03/2002WO2002076443A1 Use of breakers of advanced glycation endproducts for treating deleterious effects of aging and debilitating diseases
10/03/2002WO2002076440A2 Methods of treating alzheimer's disease with piperidin derivates
10/03/2002WO2002076437A2 Methods for treating neurodegenerative diseases including alzheimer's
10/03/2002WO2002076404A2 Fatty alcohol drug conjugates
10/03/2002WO2002076402A2 Fatty amine drug conjugates
10/03/2002WO2002076400A2 Inosine compounds and their use for treating or preventing an inflamation or a reperfusion disease
10/03/2002WO2002076390A2 Methods for treating stress disorders using glucocorticoid receptor-specific antagonists
10/03/2002WO2002076388A2 Methods for increasing analgesic potency and attenuating adverse excitatory effects of bimodally-acting opioid agonists by inhibiting gm1-ganglioside
10/03/2002WO2002076381A2 Proanthocyanidins for the treatment of amyloid and alpha-synuclein diseases
10/03/2002WO2002076229A1 One-step process for preparing chewing gum
10/03/2002WO2002076211A1 Nicotine-containing oral dosage form
10/03/2002WO2002076196A1 Transgenic animals expressing antibodies specific for genes of interest and uses thereof
10/03/2002WO2002068687A8 Function and application of tob gene in central nervous system of mammal
10/03/2002WO2002062784A8 Piperidinee derivatives as neurokinin 1 antagonists
10/03/2002WO2002062293A3 Coumarin compounds as microtubule stabilizing agents and therapeutic uses thereof
10/03/2002WO2002059127A3 Pyrazinoquinoxaline derivatives as serotonin agonists and antagonists
10/03/2002WO2002018407A3 Antisense oligonucleotides against vanilloid receptor 1
10/03/2002WO2002017921A3 Paroxetine compositions and processes for making the same
10/03/2002WO2002004949A3 Reagents and methods for identification of binding agents
10/03/2002WO2001093836A3 Encapsulation of polynucleotides and drugs into targeted liposomes
10/03/2002WO2001071004A3 Proteases
10/03/2002WO2001023385A9 Novel tropane analogs
10/03/2002WO2001021812A9 Phosphatases which activate map kinase pathways
10/03/2002WO2001003648A9 Oregano-based therapeutic composition
10/03/2002US20020143211 Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochlorid, processes for preparing thereof
10/03/2002US20020143185 Nitrosation process
10/03/2002US20020143177 For inhibiting beta-secretase enzyme activity and A beta peptide production, inhibition of beta-secretase enzyme activity halts or reduces production of A beta from APP and reduces or eliminates the formation of beta-amyloid deposits
10/03/2002US20020143149 Seven trans-membrane receptor-Fitz2
10/03/2002US20020143145 Detcting moduators of binding activity of preferential membrane proteins; obtain animal, incubate with modulator, monitor adjustment in activity from recptors
10/03/2002US20020143105 Providing test sample comprising a polypeptide that contains a discordant helix in form of alpha-helix; contacting test sample with test compound; determining rate of decrease amount of alpha -helix in ttest sample
10/03/2002US20020143067 Novel uses of dl-THP
10/03/2002US20020143065 Useful for the delivery of the (+) tramadol enantiomer and the (-) tramadol enantiomer
10/03/2002US20020143058 Blending ingredients including a hygroscopic salt of valproic acid, carbomer, and non-hygroscopic additive to form non-hygroscopic stable oral pharmaceutical formulation
10/03/2002US20020143053 Carbamate compounds for use in preventing or treating anxiety disorders
10/03/2002US20020143040 Having antipyretic action, analgesic action, anti-inflammatory action;side effect reduction
10/03/2002US20020143032 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
10/03/2002US20020143029 Tetrahydronaphthyridinyl-carboxamides having anti-convulsant activity
1 ... 1293 1294 1295 1296 1297 1298 1299 1300 1301 1302 1303 1304 1305 1306 1307 1308 1309 1310 1311 1312 1313 ... 1833